Profile

Nanology Labs has developed a tumor modulating theranostic agent, Manganescan, with capability to oxygenate tumors and kill cancer cells in combination with radiation therapy. This product is also able to detect early stage tumors with high accuracy using MRI. The combination of Manganescan with radiation therapy can improve the life-expectancy by 5-fold and achieve 40% cure rate. Manganescan offers a safer and effective approach to treat solid tumors via minimalizing the total radiation doses and the risk to normal tissues and presenting a broad applicability across multiple tumor types.

Nanology Labs logo

Website

nanologylabs.com

Contact

Event details

Date: September 14 - 16, 2020

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences

Participants

16 in total
  • Artenga Inc.
    Artenga’s microbubble drug conjugates (MDC) are used with focused ultrasound (FUS) as a key…
  • Chip Care
    ChipCare is a Toronto-based pre-revenue company, developing a point-of-care platform which will have the unique…
  • CURIATO
    Curiato is pioneering a non-invasive patient monitoring platform for healthcare. Our platform relies on our smart bed…
  • Exact Imaging
    Exact Imaging is the world’s leader in high-resolution micro-ultrasound systems enabling real-time imaging and guided…
  • KA Imaging
    KA Imaging has created color x-ray that allows for bone and soft tissue separation similar to CT, but at a fraction of…
  • Lumasonix Inc.
    The low-cost Lumasonix Blood Test (LBT) provides crucial information about otherwise undetectable cancer…
  • Mediphage Bioceuticals Inc.
    Mediphage Bioceuticals is a genetic medicine company developing safe, effective, and accessible cures for chronic and…
  • Nanology Labs
    Nanology Labs has developed a tumor modulating theranostic agent, Manganescan, with capability to oxygenate tumors and…
  • OPTT Inc.
    OPTT is a digital mental health platform equipping healthcare organizations with a comprehensive package of digital…
  • OVENSA
    Ovensa is a Canadian preclinical stage company developing a siRNA drug candidate silencing the overexpression of…
  • SaluTech
    SaluTech has developed a proprietary conductive biomaterial (CBM) to treat patients suffering from Atrial…
  • Swan Cytologics
    The SWANglide ultrasound-enhanced needle biopsy from Swan Cytologics improves patient outcomes and reduces healthcare…
  • Thornhill Medical
    Thornhill Medical is a Canadian designer and manufacturer of innovative healthcare technology. Our product portfolio…
  • Ventripoint Diagnostics
    Ventripoint Diagnostics is a medical device company engaged in the development and commercialization of a breakthrough…
  • VeriLuce Therapeutics
    VeriLuce Therapeutics is an early-stage company currently focusing on the computational design and development of small…
  • Vitreo Pharma
    Vitreo Pharma is a developmental stage company that utilizes a polypharmacology strategy to generate our lead, first-in…